Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A University of Michigan pilot study found that identifying a patient's mutational landscape can match them with existing clinical trials based on biomarkers. The study aimed to overcome practical challenges in sequencing genetic material from advanced or treatment-resistant cancer patients.
A study published in CMAJ found that cancer survivors have a 2.2-fold increased risk of developing a second primary cancer of the same type as their first, while a second cancer of a different type has only a 1.1-fold increased risk. The risk varies depending on the type of cancer.
A new treatment combination of radiation therapy and LY2109761 blocks TGF-β signaling pathways, slowing down tumor cell self-renewal and growth. This combination therapy improved outcomes in animal models and has the potential to delay glioblastoma progression in patients.
Researchers found that six out of ten cancers were more common in HIV-infected patients, including Kaposi's sarcoma and non-Hodgkin lymphoma. Earlier antiretroviral therapy may help maintain immune function and reduce cancer risk.
A recent study published in Clinical Cancer Research found that arginine supplementation can reactivate cancer-fighting T-cells in patients with glioblastoma. This is achieved by replenishing the amino acid arginine, which is depleted due to persistent neutrophil activity. The result is an improved immune response against cancer cells.
Mortality rates for patients with oral cavity and pharynx cancer have decreased significantly between 1993 and 2007. The largest declines were observed among black men and women with at least 12 years of education, suggesting that improvements in detection, treatment, and risk factors contribute to these decreases.
Researchers at the University of Michigan Comprehensive Cancer Center discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers. These rearrangements, seen in the MAST kinase and Notch family genes, can give scientists targets for potential therapies.
Researchers discovered that the genes AURKA and MYCN were overexpressed in neuroendocrine prostate cancers, leading to the inhibition of tumor growth by PHA-739358. This study provides new hope for treating a highly lethal form of prostate cancer.
A new device developed at the University of Colorado Cancer Center uses gold nanoparticles to detect lung cancer in exhaled breath, distinguishing between small-cell and non-small-cell lung cancer. The device has shown promising results in preliminary studies, with the potential to revolutionize lung cancer screening and diagnosis.
Researchers developed a new genetic screening tool to investigate possible treatments for patients with melanoma and unique genetic mutations. The study found that vemurafenib was most effective in melanomas with the V600E mutation, while vincristine only worked on those without BRAF gene mutations.
Scientists discovered that variant forms of tyrosine can slow tumor growth and prevent metastasis. This finding could lead to a simple and safe type of therapy to manage malignant disease.
Researchers identified ALK amplification in up to 86% of inflammatory breast cancer patients, a potentially targeted therapy approach. Inhibiting ALK with a small-molecule inhibitor resulted in tumor cell death, paving the way for clinical trials.
A new study found that a novel histone deacetylase inhibitor drug, entinostat, can predict clinical benefit in breast cancer patients just days after treatment. The study showed that levels of protein lysine acetylation were related to clinical benefit, with patients who had elevated levels having a reduced risk of disease progression.
A study suggests targeting ALK-1 with PF-03446962 may help patients whose cancer does not respond to existing antiangiogenic therapies. The agent showed partial responses and stable disease in seven out of 44 patients, including those with lung, renal or liver cancer.
Researchers developed a phenotypic screening platform to predict cancer drug success, identifying over 100 lead compounds with antitumor activity. The platform ensures unbiased analysis of complex tumor systems, revealing new interactions relevant for disease treatment.
A recent study found that antifolate drugs may be effective against non-small cell lung cancer (NSCLC) patients with specific mutations in the KRAS gene. The treatment can stop the KRAS gene from being expressed, leading to cancer cell death.
Researchers have identified potential mechanisms to prevent drug-induced skin lesions in BRAF mutation-positive melanoma patients treated with current therapies. Next-generation BRAF inhibitors may also represent a novel single-agent treatment option, avoiding this side effect and extending treatment durability.
Researchers found a significant increase in median survival time for patients with recurrent metastatic non-small cell lung cancer treated with a combination epigenetic therapy. The study, funded by SU2C and the National Cancer Institute, showed four patients achieving major objective responses to subsequent treatments.
A new clinical test called SNaPshot allows doctors to identify patients' individual genotypes and target tumours with the most appropriate therapy. The test has been shown to significantly improve response rates in non-small-cell lung cancer patients.
A recombinant poxviral vaccine has shown positive responses in both metastatic breast cancer and ovarian cancer, with median overall survival ranging from 13.7 months to 15 months. The treatment led to clinical responses in some patients and mild injection-site reactions as the most common side effect.
Almac's innovative test identifies patients who may benefit from chemotherapy, offering a breakthrough in managing stage 2 colon cancer. The technology uses genetic signatures to predict cancer recurrence, providing doctors with a valuable tool to improve patient outcomes.
A new study found that older women with breast cancer are not experiencing the same improvements in treatment and detection as younger women. The study, published in the Journal of Clinical Oncology, reveals a discrepancy between age groups when it comes to breast cancer outcomes.
A phase III trial found that concurrent chemo-radiotherapy significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma. The treatment regimen resulted in higher progression-free and distant metastasis-free survival rates compared to radiation alone.
A potential EBV vaccine could prevent infectious mononucleosis and cancers linked to the virus. Researchers prioritize studying immune responses to vaccination and identifying biological markers for cancer prediction.
Patients aged 60-75 who received the mini-transplant experienced comparable survival rates across three age groups, with increased comorbidities and cancer aggressiveness affecting outcomes. The five-year survival rate was 35% for overall and 32% for disease-progression free
The algorithm identifies high-risk patients for gastro-oesophageal and lung cancers at an earlier stage by analyzing symptoms and risk factors. It shows that the top 10% of predicted patients accounted for 77% of all diagnosed cases over two years.
Researchers found that women related to a patient with a hereditary breast cancer mutation but without the mutation themselves have no increased risk. The study settles a controversy and supports current practice guidelines advising non-carriers on no additional risk attributable to their family-specific BRCA1 or BRCA2 mutation.
A new interactive training tool developed by a Duke University researcher has been shown to increase empathic responses from oncologists and improve patient trust. The computer-based tutorial provides feedback on recorded visits with patients, offering an alternative to expensive courses.
A decade-long study found that regular aspirin intake halves the risk of developing hereditary cancers, including bowel and womb cancers. The study involved nearly 1,000 patients and found a 50% reduction in incidences of hereditary cancer among those taking aspirin.
A randomized controlled trial has shown that long-term use of aspirin can reduce colorectal cancer incidence by over 60% in patients at genetically increased risk. The study involved nearly 1,000 patients with Lynch Syndrome and found a significant reduction in cancer incidence after five years of aspirin treatment.
A recent study found that high fluid intake is associated with a 24% reduced risk for bladder cancer among male participants. The association was strongest among younger men and may be due to the flushing out of potential carcinogens by fluids.
Researchers have identified four new 'ZIP codes' in the human blood vessel network that could help fight cancer, obesity and other diseases. These shared addresses were found to be associated with specific receptors and ligands, opening up new avenues for targeted therapies.
Postmenopausal women who used nonsteroidal anti-inflammatory drugs for at least 10 years had a significantly lower risk of death from colorectal cancer compared to those who did not use these medications. The study found that consistent NSAID use over time was associated with a 30% lower rate of colorectal cancer mortality.
Research found associations between obesity and increased risk of non-Hodgkin lymphoma in young adults. Diets high in trans fats and low in vegetables were also linked to a higher risk, while those with high vegetable intake had a lower risk. Obesity was particularly strong in men, who had a 64% higher risk of developing NHL.
Researchers found that an antiparasitic agent used to treat African sleeping sickness may provide long-term protection against nonmelanoma skin cancers. The study, conducted on 209 participants, showed a reduced incidence of skin cancers among those who took the drug for five years compared to those who received a placebo.
Researchers at Huntsman Cancer Institute have discovered a new way to model human breast cancer that could lead to predicting which breast cancers will spread. The model was created using tumor tissue grafted into mouse mammary glands and found that it accurately predicted the behavior of human breast cancers.
A phase 2 trial shows that combining standard chemotherapy with a new cancer vaccine enhances treatment effect and slows disease progression in NSCLC patients. The vaccine stimulates an immune response against the MUC1 protein, which is overexpressed in 60% of NSCLCs.
A Mayo Clinic study has found that a baseline PSA test in men aged 40-60 can predict the risk of subsequent and low-risk prostate cancer. The study, which followed over 600 men for prostate outcomes, showed that men with elevated PSA levels were more likely to undergo biopsies and be diagnosed with low-risk cancer.
Researchers have found a biomarker that can rapidly identify severe graft-versus-host disease of the intestine in hematopoietic cell transplant patients with leukemia, lymphoma or other blood disorders. The biomarker, REG3-alpha, helps doctors ensure patients receive appropriate treatment as early as possible.
Andrew J. Dannenberg, M.D., is recognized for his seminal contributions to understanding the inflammation-cancer connection and developing strategies to prevent breast cancer. His work has provided key insights into the role of prostaglandin biology in cancer prevention.
Scientists propose 'Lance Armstrong effect' to overcome resistance in pancreatic and other cancers, with promising results in testicular cancer patients who beat metastatic disease despite low survival rates elsewhere. Researchers explore nanoparticle therapies to target tumors with high temperatures.
Thyroid dysfunction is a common side effect of antineoplastic agents in 20-50% of cancer patients, causing fatigue, weakness, and depression. Researchers recommend screening for thyroid disease and monitoring of thyroid function tests to improve patient quality of life.
Early-stage laryngeal cancer patients receiving primary surgery have a higher four-year survival rate compared to those treated with radiation. Meanwhile, chemotherapy combined with radiation therapy has seen increased use in advanced-stage patients, improving their survival rates.
A new study published in BMC Public Health found that never-married men have a significantly higher risk of dying from cancer compared to their married counterparts. The difference in mortality between married and never-married men has increased over the past 40 years, with the gap growing from 18% to 35% for men.
The Terry Fox Research Institute is funding a $5-million program to develop new biomarkers and treatments for ovarian cancer. The program aims to identify new approaches to diagnose and manage the disease, which currently affects one in four women diagnosed with ovarian cancer.
A QUT program trains nurses to provide end-of-treatment care plans for cancer patients, reducing the need for ongoing information and emotional support. The intervention also leads to lower proportions of patients requiring emotional support and improved GP feedback on care plans.
A recent survey found high levels of anxiety and job dissatisfaction among over 2000 medical school faculty in the US. To address this, researchers propose six strategies called 'the Nepenthe principles' to enhance professional development, inclusivity, and creativity, ultimately improving productivity.
A study published in Gut found that specific types of mouth bacteria are associated with pancreatic cancer. The researchers identified two key species - Neisseria elongata and Streptococcus mitis - which were significantly less present in cancer patients' mouths, while Granulicatella adjacens levels were higher.
A study published in Cancer Prevention Research found that ginger root supplements reduced markers of colon inflammation in patients, suggesting its potential as a colon cancer prevention agent. The researchers measured standard levels of colon inflammation and found statistically significant reductions in most of these markers.
Researchers have identified a four-gene signature that accurately predicts which patients are at higher risk of oral cancer recurrence. The signature contains genes related to cell invasion and is indicative of an increased risk of recurrence even in patients with no visible signs of cancer.
Researchers developed an internet-based multimedia informed consent resource to make it easier for cancer patients to understand and feel comfortable enrolling in clinical trials. The tool, accessed via the Internet, contains a video version of the traditional informed consent process and a PDF of the written materials, allowing patien...
A study by the American Society for Radiation Oncology found that cancer patients in their 60s were more likely to use web-based technology to answer quality of life survey questions. The use of this technology increased survey completion rates from 52% to 90% six months after treatment.
A study found that most cancer care physicians initiate contact with bereaved family members and caregivers after a patient's death. However, over two-thirds of physicians reported inadequate training in this area during their residency or fellowship. The most common forms of follow-up were sending condolence letters and making telepho...
A study by the American Society for Radiation Oncology found that nearly three-quarters of cancer patients have insufficient vitamin D levels, with those deficient experiencing more advanced cancer. Vitamin D supplementation showed promise in improving serum levels and potentially impacting treatment outcomes.
A European Survey of Oncology Nurse Breakthrough Cancer Pain Practices revealed an enormous opportunity to improve pain outcomes through education, with most nurses reporting inadequate training and confusion over medication options. The survey calls for nurse-specific guidelines and training to address the gap in management.
Scientists have developed a novel technique to measure and document tumor-inducing changes in DNA, revealing the earliest stages of cancer formation. The study provides insight into chromosomal rearrangements known as translocations, which can lead to tumors in leukemias, lymphomas, and sarcomas.
The study found that many people believe cancer is curable, while others hold misconceptions about its causes and treatment options. Research suggests a need for education on the effects of diet and obesity on cancer development.
A new 'CAP50' regimen combining chemotherapy and radiation before surgery shows promise in reducing rectal cancer recurrence risk by 88% three years after treatment. The study found that the increase in radiation dose did not extend treatment duration, while avoiding side effects.
The report highlights the urgent need for simplified and integrated patient treatment pathways, new models of care with lower cost bases, and a whole new approach to expensive interventions. Radical action is required to make cancer care fair and affordable for all citizens.
The Lancet Oncology Commission emphasizes the need for affordable cancer care in high-income countries by addressing issues like overuse, rapid expansion of demand, and shortening life cycles of medical technologies. The commission suggests value-based pricing, personalized medicine, and education to tackle these challenges.